Cancer
Skin Carcinoma
CI-CAN-00001511Explore in graph →
Top-level127 active trials2 approved drugs4 evidence items
- NCIt
- C4914
- ICD-10
- C44
- MeSH
- D000099313
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001511Explore in graph →
Population statistics describe groups defined by geography, period and sex. They do not predict any individual outcome. Values labelled "estimated" or "projected" are model outputs from the source, not registry counts.
United States
Unit: per 100,000 · standard population: 2000 U.S. Std. Population
| Year | Sex | Age group | Value (per 100,000) | 95% CI | Type | Site definition | Source |
|---|---|---|---|---|---|---|---|
| 2024 | All | All ages | 1.2 | 1.2–1.3 | observed | C44 | cdc-wonder |
| 2024 | Female | All ages | 0.6 | 0.6–0.7 | observed | C44 | cdc-wonder |
| 2024 | Male | All ages | 2 | 2–2.1 | observed | C44 | cdc-wonder |
| 2023 | All | All ages | 1.2 | 1.1–1.2 | observed | C44 | cdc-wonder |
| 2023 | Female | All ages | 0.6 | 0.6–0.7 | observed | C44 | cdc-wonder |
Showing the 12 most recent rows of 21; every year is plotted above and available via the API.
Data updated 21 days agoSource updated D158 vintage 2024
United States
Unit: count
United States
Unit: per 100,000
Data updated 21 days agoSource updated unknown63 observations
| 2023 | Male | All ages | 1.9 | 1.8–2 | observed | C44 | cdc-wonder |
| 2022 | All | All ages | 1.1 | 1.1–1.2 | observed | C44 | cdc-wonder |
| 2022 | Female | All ages | 0.6 | 0.5–0.6 | observed | C44 | cdc-wonder |
| 2022 | Male | All ages | 1.9 | 1.8–2 | observed | C44 | cdc-wonder |
| 2021 | All | All ages | 1.1 | 1.1–1.1 | observed | C44 | cdc-wonder |
| 2021 | Female | All ages | 0.6 | 0.6–0.6 | observed | C44 | cdc-wonder |
| 2021 | Male | All ages | 1.8 | 1.7–1.9 | observed | C44 | cdc-wonder |
| Year | Sex | Age group | Value (count) | 95% CI | Type | Site definition | Source |
|---|---|---|---|---|---|---|---|
| 2024 | All | All ages | 5,462 | — | observed | C44 | cdc-wonder |
| 2024 | Female | All ages | 1,566 | — | observed | C44 | cdc-wonder |
| 2024 | Male | All ages | 3,896 | — | observed | C44 | cdc-wonder |
| 2023 | All | All ages | 5,062 | — | observed | C44 | cdc-wonder |
| 2023 | Female | All ages | 1,538 | — | observed | C44 | cdc-wonder |
| 2023 | Male | All ages | 3,524 | — | observed | C44 | cdc-wonder |
| 2022 | All | All ages | 4,845 | — | observed | C44 | cdc-wonder |
| 2022 | Female | All ages | 1,404 | — | observed | C44 | cdc-wonder |
| 2022 | Male | All ages | 3,441 | — | observed | C44 | cdc-wonder |
| 2021 | All | All ages | 4,543 | — | observed | C44 | cdc-wonder |
| 2021 | Female | All ages | 1,360 | — | observed | C44 | cdc-wonder |
| 2021 | Male | All ages | 3,183 | — | observed | C44 | cdc-wonder |
Showing the 12 most recent rows of 21; every year is plotted above and available via the API.
Data updated 21 days agoSource updated D158 vintage 2024
| Year | Sex | Age group | Value (per 100,000) | 95% CI | Type | Site definition | Source |
|---|---|---|---|---|---|---|---|
| 2024 | All | All ages | 1.6 | 1.6–1.6 | observed | C44 | cdc-wonder |
| 2024 | Female | All ages | 0.9 | 0.9–1 | observed | C44 | cdc-wonder |
| 2024 | Male | All ages | 2.3 | 2.2–2.4 | observed | C44 | cdc-wonder |
| 2023 | All | All ages | 1.5 | 1.5–1.6 | observed | C44 | cdc-wonder |
| 2023 | Female | All ages | 0.9 | 0.9–1 | observed | C44 | cdc-wonder |
| 2023 | Male | All ages | 2.1 | 2.1–2.2 | observed | C44 | cdc-wonder |
| 2022 | All | All ages | 1.5 | 1.4–1.5 | observed | C44 | cdc-wonder |
| 2022 | Female | All ages | 0.8 | 0.8–0.9 | observed | C44 | cdc-wonder |
| 2022 | Male | All ages | 2.1 | 2–2.2 | observed | C44 | cdc-wonder |
| 2021 | All | All ages | 1.4 | 1.3–1.4 | observed | C44 | cdc-wonder |
| 2021 | Female | All ages | 0.8 | 0.8–0.9 | observed | C44 | cdc-wonder |
| 2021 | Male | All ages | 1.9 | 1.9–2 | observed | C44 | cdc-wonder |
Showing the 12 most recent rows of 21; every year is plotted above and available via the API.
Data updated 21 days agoSource updated D158 vintage 2024